BRIEF-20 People In Japan Who Took Amgen's Tavneos Have Died, And At Least 22 Developed A Potentially Fatal Liver Injury, As Per Kissei Pharmaceutical- WSJ

Amgen Inc.

Amgen Inc.

AMGN

0.00

May 15 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T:

  • 20 PEOPLE IN JAPAN WHO TOOK AMGEN’S TAVNEOS HAVE DIED, AND AT LEAST 22 DEVELOPED A POTENTIALLY FATAL LIVER INJURY, AS PER KISSEI PHARMACEUTICAL- WSJ

  • KISSEI TOLD DOCTORS FRIDAY TO STOP PRESCRIBING AMGEN'S TAVNEOS DRUG TO NEW PATIENTS - WSJ

Source text: https://tinyurl.com/mrk4hevp

Further company coverage: 4547.T


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.